Study summary
Low-dose semaglutide reduced craving and drinks on drinking days
What was tested
Weekly low-dose semaglutide or placebo for 9 weeks in adults with alcohol use disorder who were not seeking treatment.
What they found
- Semaglutide reduced alcohol consumed in a lab drinking test and drinks per drinking day.
- Weekly craving fell; total drinking days did not change.
What it means
Early evidence that justified the larger trials now running.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.